Granules India Ltd.-GRANULES, BSE:532482 Latest news, stock scores, research reports and price movements. Based on our forecasts, a long-term increase is expected, the "Granules India Ltd" stock price prognosis for 2026-06-01 is 869.792 INR. Premium Realtime & Alerts. If you are looking for stocks with good return, Granules India Ltd. can be a profitable investment option. Sales for the quarter grew sturdily by 33.2% y-o-y to Rs 799 crore led by a strong double digit growth of 84.4% y-o-y and 34% y-o-y in PFI (Pharmaceutical Formulation Granules India Ltd. gets 31% of its revenue from. Call Updates Granules India Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Granules India Ltd is engaged in the manufacture of active pharmaceutical ingredients (API`s) and pharmaceutical formulation intermediates (PFIs) with complete vertical integration. Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). Join to Connect Granules India Limited. Market Cap. Granules India Limited is a Public incorporated on 18 March 1991. It is classified as Non-govt company and is registered at Registrar of Companies, Hyderabad. Its authorized share capital is Rs. 505,000,000 and its paid up capital is Rs. 247,640,800. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. 52 Week High ₹ 437.95. Granules India announced that its subsidiary, Granules Pharmaceuticals Inc. is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of N- Nitrosodimethylamine (NDMA) levels above the Acceptable Daily Intake Limit. 71 reviews from Granules India Limited employees about Granules India Limited culture, salaries, benefits, work-life balance, management, job security, and more. The overall rating of Granules India is 4.1, with Job Security being rated at the top and given a rating of 4.1. Time and Venue Details: Date : Walk-In Interview 16th June 2021 from 8:00 AM to 12:00 PM at Granules India Limited Sy No. The consensus estimate represents an upside of 33.88% from the last price of 332.25. Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad/Secunderabad( Gagillapur ), Gagillapur, India. ( SAIL ), Infibeam Incorporation Limi…. Today's Low ₹ 330.2. Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD). 90 total customers. GRANULES Intraday Trading. Market Cap. Granules India's Reports. Granules India Limited is a pharmaceutical company that manufactures finished dosages (FDs), pharmaceutical formulation intermediates (PFIs) and active pharmaceutical ingredients (APIs). If intrinsic value > current price, price increase is expected in … Percentage Revenue: 15%. Intrinsic value is the calculated value of the company and may differ from current stock price. - API's. Report this profile About I am passionate about the work I do. Granules India Ltd. gets 31% of its revenue from. Granules India Ltd. is a fully integrated pharmaceutical manufacturer. Screeners Create Scan, Old. Granules India Limited. Its authorized share capital is Rs. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited. About Company, Granules is a world class, large scale manufacturing company partnering with market leaders to offer pharmaceutical products and services. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Articles on Granules India Ltd, Complete Coverage on Granules India Ltd Granules India Limited is one of the vertically integrated growing pharmaceutical manufacturing companies in India today. 122.7 cr: Sharekhan Walk-in Interview for Inter Fresher- Granules India Limited (Gagillapur) Age: 18-20 Passed out Year: … Granules India is hiring For Freshers.Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. Reco - This broker has downgraded this stock from it's previous report. Investment Checklist. ZPPHigh school revuru. There are 21 companies in the GRANULES INDIA LIMITED corporate family. Granules India Limited (Granules) reported a strong performance for the quarter, with the adjusted PAT largely in line with estimates. Videos related to: GRANULES NEWS why is Granules India Limited price falling or rising . Granules India Ltd. share price forecast. Market Cap: ₹88,304 Cr. However, Salary & Benefits is rated the lowest at 3.6. Every investor in Granules India Limited (NSE:GRANULES) should be aware of the most powerful shareholder groups.Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. the stock should touc.. tradingview About Granules India Limited :-Established in 1991 , Granules India Limited has made a name for itself in the list of top suppliers of in India. After training employment will be given in Granules India ltd. During training stipend will be paid. Find the latest GRANULES INDIA LTD. (GRANULES.BO) stock quote, history, news and other vital information to help you with your stock trading and investing. Granules India Limited | 21,405 followers on LinkedIn. Granules is looking to increase contribution of the high-margin FD segment to 60% over the next the 2-3 years The … They manufacture Active Phrmaceutical Ingredients(APIs), Pharmaceutical formulation Intermediates(PFIs) and Finished Dosages(FDs), distributed to quality consious customers in both regulated and semi-regulated markets. Sign up for PRO account to check bulk details and Address. Today's High ₹ 337. Quality Control Microbiologist at granules india limited Kota, Andhra Pradesh, India 500+ connections. Volumes in the last session was 2064904, out of which 823257 went into delivery, which is … Peer Name. 1995 - Becomes a public listed company. Basic Pro. More announcements and NEWS . Find their customers, contact information, and details on 5019 shipments. The Company manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) which are distributed in over 55 countries. Contact Person: Ms.Mr.Granules Tel: +91 40 6676 0000 Fax: +91 40 2311 5145 Address: Granules India Limited 8-2-293/A/A/2, Rd NO.2, Banjara Hills, Hyderabad, Hyderabad, India Zip: Hyderabad- 500 081 Country/Region: India Province/State: Hyderabad City: Hyderabad Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. See exports to Granules Usa Inc.. Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Charts Candlestick, P&F. Based out of Hyderabad, India, the company operates into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Address: 8-2-293/A/A/2, Road No.2, Banjara Hills, City: Hyderabad, Ap, Pin: 500034. READ MORE. Price Summary. in FY2016. It is classified as Non-govt company and is registered at Registrar of Companies, Hyderabad. 2019 - Granules India commenced commercial operations of Granules Pharmaceuticals Inc. (GPI), their US subsidiary. Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. 22 Jan 2019. This is GST number of Andhra Pradesh state. Granules India Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2020. Granules India Consolidated December 2020 Net Sales at Rs 844.51 crore, up 19.97% Y-o-Y 12.04.2021 Granules Q4 PAT seen up 253.6% YoY to Rs. Granules Stock Analysis, Research, Granules Candlestick Chart Live. Intrinsic Value. Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. This specialisation enables us to offer an optimal blend of high quality products, at a competitive cost. This business was registered under GST on 01/07/2017. Dr. Reddy's Laboratories Limited. Company Announcement Granules India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 - NEWS as on 2021-03-30 . Granules India Ltd. is a fully integrated pharmaceutical manufacturer. The Company manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) which are distributed in over 55 countries. This article provides in-depth fundamental analysis of Granules India Ltd, a Hyderabad-based Indian integrated pharmaceutical manufacturer, which focuses on making active pharmaceutical ingredients (API), pharmaceutical formulation intermediates (PFI) and finished dosages (FD) as primary business activities. Call ImportGenius Join ImportGenius to see the import/export activity of every company in the United States. Dr. Reddy's Laboratories Limited. 327.85 4.50 (+1.39 %) Place Order. Export Shipments. The current status of Granules India Limited is - Active. Granules India limited is good company They have four API unit and one PFI unit in India and one unit in USA, UDFDA, EDQM and Coffeprise regulatory approved plant Was this review helpful? Granules India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 28, 2021, inter alia, has declared third interim dividend of 25 paise per share of face value of Re. Granules India Limited Is Manufacturer, Supplier, Importer & Exporter Of Active Pharmaceutical Ingredients, API's Under Development, Pharmaceutical Formulation Intermediates and PFI's using Multiple API's Under Development. - API's. 07 Mar 2018. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. The average salary for Granules India Limited employees in India is ₹518,118 per year. About the company. granules india ltd for bse:granules by trailingtrades. In Granules India , the EPS growth was 174.39 % which is good for the company. Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Granules India has OPM of 21.26 % which is a good sign for profitability. Granules India Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31 … Call … Granules India Ltd. Job as Business Development Manager. (M.P.C. Get the latest Granules India Ltd (GRANULES) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The supplier company is located in Visakhapatnam, Andhra Pradesh and is one of the leading sellers of listed products. To know first hand how is it like to work at Granules India read detailed reviews by job profile, department and location in the reviews section. The analysis of debt levels of Granules India Ltd over last 10 years (FY2007-16) indicates that the debt of Granules India Ltd has increased from ₹134 cr. Walk-In Interview for warehouse- Granules India Ltd (Formulation-OSD) Department: Warehouse … in FY2007 to ₹474 cr. Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 8729.30 Crore) operating in Pharmaceuticals sector. Reviews from Granules India Limited employees about Granules India Limited culture, salaries, benefits, work-life balance, management, job security, and more. Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, India. Granules India Ltd. GRANULES. Granules India down by -1.13% is trading at ₹ 329.55 today. UDAY REDDY | Greater Hyderabad Area | Assistant Manager -QA at Granules India Limited | 38 connections | View UDAY's homepage, profile, activity, articles Percentage Revenue: 15%. 1/- each representing 25% of paid-up capital for the financial year 2020-21. Granules India Limited (Granules) is witnessing a robust outlook across segments and the finished dosages (FD) segment is expected to be a key growth driver. Customers of GRANULES INDIA LIMITED. Granules India Limited Share Price Today, Live NSE Stock Price: Get the latest Granules India Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account, research, results and more details at NSE India. Granules India Limited is a Public incorporated on 18 March 1991. Granules India Limited stock tips (delivery Volume analysis) Total 5 day volume for Granules India Limited is 11758618, out of which 4887613 went into delivery, which is 41.57 percent of total volumes. GRANULES INDIA LIMITED has 3029 total employees across all of its locations and generates $360.72 million in sales (USD). GRANULES INDIA LIMITED is located in Hyderabad, Telangana, India and is part of the Pharmaceutical Manufacturing Industry. Analyse safety of investment in Granules India Limited with Pledged Shares Data and 10 Years Income vs Operating Cashflow, Debt Equity Ratio, Current Ratio etc. Granules India Limited. Minimize Indicators. Granules India secures USFDA approval for Potassium Chloride Oral Solution Hyderabad: Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules … after a jump of 400% this stock is going to be range-bound for some time. 300-310 is the support for the short term. 8 smallcaps where MFs hiked stakes in Q4. US Customs Records Notifications available for Granules India Limited, a supplier based in India. Granules India announced that its subsidiary, Granules Pharmaceuticals Inc. is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of N- Nitrosodimethylamine (NDMA) levels above the Acceptable Daily Intake Limit. Bullish (Small) : Steel Authority of India Li…. Market Cap: ₹88,304 Cr. As a result, Granules India Ltd has to rely on additional sources of funds, both equity as well as debt, to fund its growth requirements. Granules India Limited, is a premier company that exports and imports goods from countries including Singapore , Germany and host of other countries. Latest Granules India Ltd News and Updates, Special Reports, Videos & Photos of Granules India Ltd on The Hindu BusinessLine. 24 Nov 2017. Reviews from Granules India Limited employees about Granules India Limited culture, salaries, benefits, work-life balance, management, job security, and more. Contact Us support@chartink.com. The 17 reports from 6 analysts offering long term price targets for Granules India Ltd. have an average target of 444.83. Granules India Limited - Analysts/Institutional Investor Meet/Con. Visit PayScale to research Granules India Limited salaries, bonuses, reviews, benefits, and more! India Ratings Affirms Granules India at ‘IND A+’/Positive; Limits Enhanced. Granules India secures USFDA approval for Potassium Chloride Oral Solution Hyderabad: Granules India Limited announced that the US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules … Buy Granules India, target price Rs 375: IIFL. Granules India Ltd. Granules India Limited is a global pharmaceutical company engaged in the manufacturing and selling of Active Pharmaceutical Ingredients … To take care of the lab work … Granules India Limited has informed the Exchange that Board of Directors at its meeting held on May 11, 2021, recommended Final Dividend of 0.75 per equity share. Contact Person: Ms.Mr.Granules Tel: +91 40 6676 0000 Fax: +91 40 2311 5145 Address: Granules India Limited 8-2-293/A/A/2, Rd NO.2, Banjara Hills, Hyderabad, Hyderabad, India Zip: Hyderabad- 500 081 Country/Region: India Province/State: Hyderabad City: Hyderabad Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). 332.25 +2.6 (0.79%) NSE: 11 Jun 03:59 PM. Granules India Ltd. quote is equal to 332.150 INR at 2021-06-11. 1991 - Granules India Limited was incorporated. Peer Name. India Ratings Assigns Granules India’s Additional Bank Loans Final ‘IND A+’/Positive. 52 Week Low ₹ 194.1. Granules India Limited. Granules India Limited Walk-in interview 2021. Roll DISPROQUIMEX S R L DE CV Drug QUIMACA Y FARMACIA Hcl HERITAGE PHARMACEUTICALS Usp GRANULES USA Drum LABORATORIO CHILE S A Residue HELM DE MEXICO SA GLAXO SMITHKLINE USA Metformin MYLAN PHARMACEUTICALS Transmission Shaft ABSOLUTE BROKERAGE CUSTOMS SC Md2 … See fundamentals, technicals, peer comparison, shareholding change
Why Is It Hard To Hire Restaurant Workers,
Natural Resources In The Coastal Plains,
Uzbekistan Open Covid,
Upmarket Fiction Word Count,
Coopers Sparkling Ale Singapore,
Owens Corning Blown Insulation,